Science Explorer Back to mapMap
Discussion
Researcher · Institute of Virology of the Slovak Academy of Sciences · Slovakia

Martina Labudová

Martina Labudová publishes mostly in Molecular Biology, Materials Chemistry and Infectious Diseases, on topics such as Enzyme function and inhibition, Cancer, Hypoxia, and Metabolism and Nanoplatforms for cancer theranostics.

ORCID 0000-0002-3197-9763 OpenAlex
World rank
#5,934,280
of 7,710,434 ranked researchers
Rank in Slovakia
#6,847
of 12,450
Works
37
Citations
616
Citations per work
16.6
h-index
15
i10-index 19Top 50% in Molecular Biology
Martina Labudová

What does Martina Labudová research?

Martina Labudová's work is mostly in Biochemistry, Genetics and Molecular Biology (28%), Medicine (15%), Materials Science (13%).

Everything else: 14 works · 37.3% of their workLife Sciences: 10 works · 27.5% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 27.5% of their workMolecular Biology: 8 works · 21.6% of their workCancer Research: 2 works · 5.9% of their workPhysical Sciences: 8 works · 20.5% of their workMaterials Science: 5 works · 12.7% of their workMaterials Chemistry: 5 works · 12.7% of their workEngineering: 3 works · 7.8% of their workBiomedical Engineering: 3 works · 7.8% of their workHealth Sciences: 5 works · 14.7% of their workMedicine: 5 works · 14.7% of their workInfectious Diseases: 3 works · 8.8% of their workEpidemiology: 2 works · 5.9% of their workTHEIR WORKMartina Labudová37works
Life Sciences28%Physical Sciences20%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1437.3%
    1. Biochemistry, Genetics and Molecular Biology1027.5%
    1. Materials Science512.7%
    2. Engineering37.8%
    1. Medicine514.7%
  1. 1Molecular Biology22% of their works
  2. 2Materials Chemistry13% of their works
  3. 3Infectious Diseases9% of their works
  4. 4Biomedical Engineering8% of their works
  5. 5Cancer Research6% of their works
  6. 6Epidemiology6% of their works

Research topics

Which keywords describe Martina Labudová's research?

The keywords of their largest research topics: Tumor Hypoxia, Inhibitors, Pathogenesis, Vaccine, Activators, Carbonic Anhydrases, Immunotherapy and Tumor Targeting.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Tumor Hypoxia122 topics
  2. Inhibitors102 topics
  3. Pathogenesis82 topics
  4. Vaccine82 topics
  5. Activators71 topic
  6. Carbonic Anhydrases71 topic
  7. Immunotherapy72 topics
  8. Tumor Targeting72 topics
  9. Gene Therapy62 topics
  10. HIF-151 topic
  11. Warburg Effect51 topic
  12. Ebola Virus41 topic
  13. Nanoparticles41 topic
  14. Norovirus41 topic
  15. Outbreak41 topic
  16. Photothermal Therapy41 topic
  17. Rotavirus41 topic
  18. AAV31 topic
  19. Arginine Deprivation31 topic
  20. Bacterial Therapy31 topic
  21. DNA31 topic
  22. Topoisomerases31 topic
  23. Viral Vectors31 topic

Where does Martina Labudová work?

Martina Labudová's main affiliation in the publication record is Institute of Virology of the Slovak Academy of Sciences, Slovakia.

How many publications and citations does Martina Labudová have?

OpenAlex counts 37 works and 616 citations for Martina Labudová, an h-index of 15, ranking #5,934,280 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Martina Labudová. Posts are plain text and can be reported.